These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30902738)

  • 1. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
    Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
    Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
    Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
    Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression.
    Chang JP; Chang SS; Yang HT; Palani M; Chen CP; Su KP
    Brain Behav Immun; 2015 Feb; 44():28-31. PubMed ID: 25452150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
    Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
    Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
    Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
    Cussotto S; Delgado I; Oriolo G; Kemper J; Begarie D; Dexpert S; Sauvant J; Leboyer M; Aouizerate B; Martin-Santos R; Schaefer M; Capuron L
    Depress Anxiety; 2022 May; 39(5):407-418. PubMed ID: 35357051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.
    Tayama J; Ogawa S; Nakaya N; Sone T; Hamaguchi T; Takeoka A; Hamazaki K; Okamura H; Yajima J; Kobayashi M; Hayashida M; Shirabe S
    J Affect Disord; 2019 Feb; 245():364-370. PubMed ID: 30423463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
    Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
    Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 polyunsaturated fatty acids supplementation improves memory in first-diagnosed, drug-naïve patients with depression: Secondary analysis of data from a randomized controlled trial.
    Xue Y; Wang L; Liu T; Zhao T; Xie K; Guo J; Chen J; Tang H; Tang M
    J Affect Disord; 2024 Apr; 350():403-410. PubMed ID: 38244783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
    Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
    JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
    Park Y; Park YS; Kim SH; Oh DH; Park YC
    Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
    Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
    JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.
    Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
    BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mothers, Omega-3 and mental health study.
    Mozurkewich E; Chilimigras J; Klemens C; Keeton K; Allbaugh L; Hamilton S; Berman D; Vazquez D; Marcus S; Djuric Z; Vahratian A
    BMC Pregnancy Childbirth; 2011 Jun; 11():46. PubMed ID: 21696635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1-year treatment with highly purified omega-3 fatty acids on depression after myocardial infarction: results from the OMEGA trial.
    Zimmer R; Riemer T; Rauch B; Schneider S; Schiele R; Gohlke H; Diller F; Steinbeck G; Katus H; Senges J;
    J Clin Psychiatry; 2013 Nov; 74(11):e1037-45. PubMed ID: 24330904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
    Su KP; Huang SY; Chiu TH; Huang KC; Huang CL; Chang HC; Pariante CM
    J Clin Psychiatry; 2008 Apr; 69(4):644-51. PubMed ID: 18370571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
    Kelaiditis CF; Gibson EL; Dyall SC
    Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial.
    Su KP; Lai HC; Yang HT; Su WP; Peng CY; Chang JP; Chang HC; Pariante CM
    Biol Psychiatry; 2014 Oct; 76(7):559-66. PubMed ID: 24602409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders.
    Liu JJ; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
    J Clin Psychiatry; 2013 Jul; 74(7):732-8. PubMed ID: 23945451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.